Headline
The latest stories from AHA Today.
The National Institutes of Health has launched a global clinical trial to test a potential COVID-19 treatment that combines remdesivir with a highly concentrated antibody solution.
A bipartisan group of 32 senators expressed concerns that the Department of Health and Human Services’ Sept. 19 change to COVID-19 Provider Relief Fund reporting requirements will create uncertainty and financial hardship for hospitals, particularly those in rural areas.
The Centers for Medicare & Medicaid Services announced new repayment terms for payments received under its Accelerated and Advance Payment programs, including a longer time period before repayment, lower recoupment rates during repayment, lower interest on remaining unpaid balance, and…
The Health Resources and Services Administration Oct. 15 at 3 p.m. ET will host a webcast to provide additional information on the latest round of COVID-19 Provider Relief Funds.
Wendy Darwell will become president and CEO of the Nassau-Suffolk Hospital Council and Northern Metropolitan Hospital Association (NorMet) effective Jan. 1, succeeding Kevin Dahill when he retires Dec. 31, leaders of the organizations announced yesterday.
U.S. Surgeon General Jerome Adams, M.D., released a report urging Americans to recognize and address hypertension control as a national public health priority.
For the latest in her Leadership Rounds series of conversations with hospital and health system leaders from across the nation, AHA Board Chair Melinda Estes, M.D., is joined by Kimberlydawn Wisdom, M.D., senior vice president of community health and equity and chief wellness and diversity officer…
An estimated 7.7 million workers lost jobs with employer-sponsored health insurance between February and June during the pandemic, according to a study released by the Employee Benefit Research Institute, W.E.
The Food and Drug Administration recommended that health care providers provide written or video step-by-step instructions, in addition to verbal instructions, to patients who are self-collecting anterior nares (nasal) samples for COVID-19 testing in a health care setting.
The Food and Drug Administration warned Battelle Memorial Institute that its respirator decontamination system does not comply with the requirement in its emergency use authorization to establish internal systems that provide for timely and effective identification, communication and evaluation of…